The use of clemastine ('Tavegil') administered parenterally in acute allergic episodes
作者： D. P. J. Conroy , M. g. Wallace
DOI: 10.1185/03007997609109313
关键词:
摘要: An open study was carried out in 41 patients, requireing an emergency doctor visit because of acute allergic episode, to assess the effectiveness antihistamine, clemastine, given parenterally. The results showed that a single intramuscular injection 2 mg clemastine 'fully effective' relieving sumptoms 19 (46.3%) and gave 'some relief' 20 (48.8%). Two (4.9%) patients failed respond. No side-effects treatment were reported.
informahealthcare.com参考文章(4)
Annmarie Hedges, M. Hills, William P. Maclay, A. J. Newman-Taylor, Paul Turner, Some Central and Peripheral Effects of Meclastine, a New Antihistaminic Drug, in Man The journal of clinical pharmacology and new drugs. ,vol. 11, pp. 112- 119 ,(1971) , 10.1177/009127007101100206
Römer D, Weidmann H, Pharmacological studies on the new antihistaminic Tavegil Medizinische Welt. ,vol. 51, pp. 2791- ,(1966)
Ebner H, Eberhartinger C, Experience with a new antihistaminic in dermatology. Results of a clinical double blind trial Wiener Medizinische Wochenschrift. ,vol. 119, pp. 630- ,(1969)
Pan A, Clinical evaluation of antihistamine, HS-592, in seasonal and perennial allergic rhinitis. Annals of allergy. ,vol. 28, pp. 69- 72 ,(1970)